evolved". Citing the "Osgood Principle" from the 1950's, recent supporting evidence was described, in which the most mature differentiated cells exert positive and negative feedback upon the proliferation of their progenitor stem cells. Advanced examples in the haemopoietic series were drawn from the work of Sachs, Metcalf, Till and McCulloch, and Kurland and Moore. The blocked ontogeny hypothesis was further elaborated in the concept of "partially-blocked ontogeny", which is intended to describe a situation in which highly differentiated slowly growing tumours contain some cells which have left the proliferating pool to differentiate along the normal pathway, but are blocked somewhere short of the final organism-serving state, in harmony with earlier suggestions by Osgood, by Pierce, and by Sachs. PHENOTYPIC diversity among cancers is expressed in terms of variable rates of cell proliferation, variable degrees of differentiation, and variation in the metabolic pathways that make proliferation possible. Thus, phenotypic diversity increases the complexity of the cancer problem immeasurably. There is little doubt that if all cancers grew at the same rate and used the same metabolic pathways, the problem would have been solved by now.
Phenotypic diversity in normal tissues may occur by two mechanisms that can be thought of as representing the extremes of the range of possibilities: (1) in the evolution of species, diversity arises by adaptive mutations in the DNA complement that makes up the genotype, and (2) phenotypic diversity can arise through ontogeny, the total programme of differen-1 tiation, which has been accepted as a process that alters the availability but not the information content of the total DRNA complement. Whether the assumption of differentiation without alteration of the DNA sequences (mechanism 2) can be maintained is still a matter of speculation. In any case, we can benefit by attempting to explain the phenotypic diversity that occurs among those cancers that have incurred the least possible change in the genome. Among the more than 40 Morris hepatomas there are several that have the normal diploid number of chromosomes, though it is not claimed on that basis that the genome has not been altered (Potter, 1968a, b) .
I suggest that phenotypic diversity among cancers can be explained without the need to involve extensive change in the genotype, although change certainly occurs during the natural history of neoplastic disease when, for example, drug-sensitive tumours become resistant. Even in the absence of extensive genetic alteration, I believe that there are a multitude of stages in differentiation, prior to the terminal stage, that, if prevented from advancing toward the terminal stage, will cause a cell to retain its capacity to re-enter the proliferative cycle. Thus, vast phenotypic diversity may be explained by the occurrence of only one or a few genetic alterations that can be effective in blocking differentiation in one or several steps, with results that are compatible with return to proliferation. Along with many others, I believe that cancer is a disease of differentiation.
The problem reduces to what I have referred to (1968a) as the "minimal deviation" concept, which, in turn, can be expressed in the framework of the process of differentiation in the phrase "oncogeny is blocked ontogeny" (Potter, 1968a, b; Potter et al., 1972) , a phrase that Alexander (1972) felt was no more than a restatement of the "many similarities between foetal and cancer tissue". The phrase is, however, intended to be much more than a restatement of similarities. The point is not that cancer tissue resembles foetal tissue in some respects, it is that in important ways cancer tissue does not resemble foetal tissue. The difference lies in the word blocked. An organ from a foetal or newborn animal consists of a population of cells that are participating in an organized and orchestrated programme which takes them through a sequence of changes that are constantly tailored to make the organ as adaptive as possible to the range of environmental variation in which it evolved. In contrast, although a clonal neoplasm that develops from a cell in a particular organ may differentiate into a population that has much of the phenotypic variation seen in a population of normal cells from the same organ, it will not recapitulate the total programme leading to an orchestrated collection of organism-serving cells, because, in nmy earlier words, the cancer is a case of "blocked ontogeny", and I mean to imply that the total programme of normal ontogeny is blocked somewhere because of a change in one or more chromosomal or extrachromosomal DNA sequences in the original cell from which the neoplastic clone was derived. The concept of blocked ontogeny does not require that all the descendants of the clone must bear the genotypic defect, nor does it require that the block in ontogeny is necessarily at the embryonic or foetal stage of ontogeny for the tissue of origin. The block could conceivably come at any point between the dividing cell and the terminal stage of differentiation. It must be clear that the concept of blocked ontogeny has to include "earlyblocked ontogeny", that is, exponential proliferation of stem cells that can give rise only to two cells both of which continue to proliferate without further differentiation. In addition, the concept must include "partially blocked ontogeny" in which a substantial fraction of the tumour cell population undergoes extensive differentiation but does not progress to the normal organized terminal state. This concept was stated by me (Potter, 1968b) as follows: "There may be an extremely large number of intermediate stages between the committed hepatocyte and the adult hepatocyte, wherein a mutant gene could result in a blocked development and produce a clone of cells with a normal chromosome number, but with a propensity for continued cell replication, and with a resistance toward normal feedback controls so that the observer would call it a cancer." At that time it was also stated: "We have now reached a stage in experimental cancer research where it is possible to work with a variety of 42-chromosome* hepatomas and to show that they have diverse phenotypes. We feel that it is feasible to attempt to rationalize the diversity that occurs at this stage of trans-formation. The . On that occasion a hint of the present discussion was also indicated (ibid., p. 186).
Today, these 4 or 5 years have passed and I must attempt to justify the two-fold claim that understanding would be near at hand, and that the contributing concepts and experiments would come from more than a few individuals. My method will be to present an extended introduction, in which a number of advances will be mentioned, and to conclude with a brief mention of some work in my own laboratory seen against the background as described. PHENOTYPIC DIVERSITY IN 1956 In discussing phenotypic diversity, a useful point of departure is a symposium sponsored by the American Cancer Society in March 1956 entitled: "A Critical Appraisal of the Biochemical Characteristics of Morphologically Separable Cancers" (Cancer Res., 16, To my knowledge Steiner was the first oncologist to have the courage to say in print that "No two tumours are ever alike." Even though he spoke as a pathologist, the inference might be drawn that the statement applied to basic biochemical differences and to therapeutic response.
Diversity in chemotherapy
Karnovsky (ibid., p. 698), speaking on "Differences between Cancers in Terms of Therapeutic Responses", concluded his introduction as follows: "It can be concluded at the outset of this talk, and without much thought, that cancers differ greatly among themselves. This categorical conclusion is not a promising one to the therapist but, if true, it is so important that it should be arrived at only at the completion of a laborious analysis. It is this great diversity among cancers, particularly in the unpredictability of the therapeutic response in individual cases and in the invariable development of resistance to treatment in the responsive cases, that I am discussing today." It may be recalled by some that Dr Karnovsky died, a victim of cancer, in 1969 cancer, in (Burchenal, 1970 at the age of 55. Although the diversity he referred to still presents difficulties to the therapist, the reference to "invariable development of resistance" would have to be qualified, and in fact Dr Karnovsky lived to see some of his own patients in whom tumour cells were apparently all killed by chemotherapy before the tumours could develop resistance. Cohen (1973 Cohen ( , 1976 , Gorman et *tl. (1977) and PaceAsciak (1977 Cohen (1973 ), Gorman et al. (1977 and Pace-Asciak (1977) are a few examples. However, the particular mechanisms shown in Fig. 1 are relevant to the feedback systems to be discussed later.
THE EVOLUTION OF THEORY AND) EXPERIMENT SINCE 1956 The cell cycle To support the claim that understanding of the nature of cancer is near at hand, and to single out the names of "more than a few" individuals, is a task that is worthy of a Hubert Lecturer, but one that I approach with trepidation and humility. I have observed that, perhaps more than in any other field, the bibliographies of reviews of cancer research are studded with references to the author's work, usually In attempting to cover some aspects of the last 20 years, I will describe models of cell replication and differentiation. In my opinion, models serve as "aids to communication" entirely apart from their relation to reality (Potter, 1964) .
The first model of the cell cycle was that of Howard and Pelc (1953) who originated the well-known model based on the incorporation of radioactive thymidine into DNA (Fig. 2) .
It was not until 1963 that Lajtha, reasoning from a knowledge of events in regenerating liver, introduced the concept of another stage (Go) appended to the cell cycle. Fig. 3 is developed from his suggestion. The Go concept was introduced to account for the fact that a period of about 16 to 1 8 h elapses after partial hepatectomy in rats before the hepatocytes begin to enter the S phase (DNA synthesis). In an adult rat the great majority of the liver cells are not proliferating, and Lajtha proposed the term Go in preference to assum- Here Go is defined as any stage of differentiation, up to and including the nth stage, provided that the cell can still return to G1 and complete a cycle of proliferation at the same level of differentiation or at a more specialized level. The Go stage at any level could undergo further specialization until it reached a terminal stage (GT) at which it could no longer return to G1. The GT cell is conceptually a Gon+1 cell in the sense that the Gonth is the last cell in the Go series that can return to a G1 stage. Rates k1 and k2 are included for comparison with Fig. 4 . However, in the present chart, and particularly in regenerating liver, in which events begin from Go, kl might apply to Go-+G1 and k2 might apply to Go-iGT.
G1 stage of the cell cycle. Essentially 100%
of the hepatocytes in a young adult rat (e.g., 90 days old) are capable of returning from Go to G1, S, G2 and mitosis. In an old rat (e.g., at 2-5 years) this is not the case, as it has been estimated by Stocker and Heine (1971) (1973) and by Steel et al. (1966) to describe tumour growth. This latter model seems to make no provision for the occurrence of a Go tumour cell.
Although non-proliferating, the Go cell of, say, a young adult mammal can be defined as a cell that has 3 options: (1) it can return to the G1 stage and re-enter the proliferative cycle, (2) per 104 injected. The colonies were shown to be clonal in nature; that is, derived from a single cell (Becker et al., 1963; Abramson etal., 1977) . In 1964, further studies by the Toronto group proposed a stochastic model for the early events in a spleen colony, to explain how a clone from a single cell could develop into all the known components of the haemopoietic system (Till et al., 1964) . Nine years later, they reaffirmed their original proposition (Korn et al., 1973) . According to the stochastic model: "The decision of pluripotent stem cell (S) to self renew, differentiate to the erythroid line (E) or differentiate to the precursor of the granulocyte line (G) is a random event determined by the 3 probabilities ps, PE and PG respectively" (Korn et al., 1973 (Korn et al., 1973) . Further evolution of the experimental approach suggests that early changes may soon be visualized in individual cells by the techniques of immunofluorescence (Tsukada and Hirai, 1975) with concomitant autoradiographic visualization of cells in which DNA is labelled by 3H-thymidine (Howard and Pelc, 1953; Lajtha, 1963; Stocker and Heine, 1971; Mendelsohn and Dethlefson, 1973; Steel et al., 1966 Senn et al. (1967) in Canada. In the beginning of the cell-culture studies, the erythroid line, which had developed nicely in the spleen colonies, failed to develop in the culture dishes. However, in 1971 this deficiency was corrected by the Axelrod group (Stephenson et al., 1971 (Osgood and Krippaehne, 1955) . He stated (Osgood, 1957 ) the principle "that with the majority of cell series the homeostatic regulator is an inhibitor of arithmetic cell division and is probably produced by the most chemically mature of the differentiating cells of that series" (italics added). This most chemically mature cell is the cell that I label GT in Fig. 3 . Osgood continued: "somewhat earlier in the process of differentiation an inhibitor of the logarithmic division that constitutes the growth process must be produced. If this were the case, all that would be necessary for unlimited growth in other words, malignancy-would be the absence of the inhibitor of logarithmic growth. The simplest mechanism which could explain this decreased production of inhibitor would be the early death of the differentiating cell before it reached the stage at which the inhibitor was produced." This seems to be another way of saying that "oncogeny is blocked ontogeny" (Potter, 1968b) . In both reviews Osgood reasoned that "the inhibitor must be relatively unstable" and "only the cells immediately subjacent are affected, indicating that the inhibitor must be relatively unstable. . ." This emphasis on unstable inhibitors will be referred to later in this section. Osgood designated the stem cell ax and the next stage of differentiation an n cell, pointing out that the of cell could go to 2 ots or 1 ox+ 1 n cell, while the n cell could only produce 2 n cells or further differentiate with or without division. In Fig. 3, I equate the Go cell with
Osgood's n cell, and wish to suggest that one has to consider the fate of a population of Go cells, in the sense that from a combination of individual possibilities (2G1, 2Go or IGo+±1G) an outcome of X% Go and 100-X% G1 would be obtained.
Relating the Osgood Principle to the cancer problem, a final quote merits attention. It was proposed that "any alteration of the genetic material in the somatic alpha cell of a series which leads to early death of the corresponding n cell [and I would add: "or which leads to a failure to mature to the GT stage"] may result in a spectrum of neoplasms of corresponding cellular type, from the most acute, rapidly progressive malignant tumour to the most slowly growing benign tumour depending on how early in the life span of the n cell death [or a block] occurs" (Osgood, 1959) . This prediction has been illustrated by the case of the Morris hepatomas, since they represent a wide spectrum from poorly to highly differentiated types in which phenotypic diversity may be related to the concept of partially blocked ontogeny. Osgood developed a method for "long-term mixed cultures of human hemic cells" (Osgood and Krippaehne, 1955; Brookes and Osgood, 1959) (Maeda and Sachs, 1978 (Lotem and Sachs, 1974 ) (italics added). It is clear that the phrase "partially blocked ontogeny" and the concept of neoplastic variation all the way from complete to partially blocked ontogeny is the working hypothesis of Sachs and his colleagues, who owe me no debt in this regard. Positive feedback controls ofcolonyformation in the haemopoietic system in cell cultures
As mentioned earlier, the study of colony formation in cell cultures coincided with the demonstration of stimulating factors produced by differentiated cells near the terminal point and exerting positive feedback on the earliest progenitors. Metcalf (1973) has pointed out that "Colony formation in vitro by both granulocytic and macrophage cells is wholly dependent on the presence of adequate concentrations of a specific factor, given the operational name, colony stimulating factor (CSF)." The substance is a glycoprotein containing sialic acid (Stanley et al., 1975) and is apparently identical with the factor called MGJ in Fibach et al. (1973) or CSA by others. It has been reported that CSF from mouse cells is completely unable to replace human CSF in its action on human target cells (Kurland et al., 1978) . The action of CSF is apparently quite analogous to erythropoietin (Gruber et al., 1977) Kurland and Moore (1977a) studying the inhibitory action of the pure substance PGE1 which was demonstrably active at 10-10 M at all concentrations of CSF, while 10-5 M PGE1 produced total inhibition of colony production at all CSF concentrations. This was quickly followed in February this year by a report from Kurland et al. (1978) showing a direct relationship between CSF concentration and PGE production. In addition, by using the softagar technique, with marrow cells in the upper layer separated by a cell-free middle layer from the mononuclear leucocytes in the lower layer, they were able to demonstrate the homeostatic effect of the combined production of CSF and PGE1, and the release from colony-inhibiting action when indomethacin was apparent and no PGE1 was formed. Fig. 6 is my expression of those relationships using the symbols employed in Figs. 2 and 3 . The data reproduced from the 1978 report are shown in Fig. 7 . A further report on indomethacin effects on normal and neoplastic cell lines has also appeared (Kurland and Moore, 1977b) . Indomethacin inhibits the synthesis of prostaglandin endoperoxide and subsequent derivatives (Fig. 1.) .
With the reports that in some systems prostacyclin is much more active than PGE1, much less stable and a product of a microsomal metabolism system (Gorman et al., 1977; Pace-Asciak, 1977) Kurland et al. (1978) (data shown in Fig. 7 ) using the Go and GT symbols from Figs. 3 and 5, and G1, S, G2 and M as in Fig. 2 . CSF is colony stimulating factor; for other abbreviations (CSA and MGI) see text. PGE is prostaglandin El (Kurland et al., 1978) . (+)ve, positive feedback; (-)ve, negative feedback. In(lomethacin is an inhibitor of the synthesis of prostaglandin endoperoxides and subsequent products (Fig. 1) ) that 4 or 5 years would result in great advances in the understanding of differentiation in normal and neoplastic cells.
STUDIES ON LIVER AND HEPATOMAS
The advances in the understanding of differentiation and proliferation in the haemopoietic system are by no means equalled in the case of parenchymal liver cells, although a large amount of literature is accumulating (Tsanev, 1975) . In the case of carcinogenesis in liver, the experimental material and techniques now available merit intensive work on the hypothesis that in liver "oncogeny is partially blocked ontogeny", for, paraphrasing the opening words of a paper on myeloid leukaemic cells by Lotem and Sachs (1974) " [Hepatoma] cells blocked in various stages of cell differentiation can be of value in elucidating the mechanism of differentiation and the blocks that can occur during carcinogenesis." As in the examples provided by the studies on myeloid leukaemic cells, I believe that the Morris hepatomas are blocked in various sequences in the process of cell differentiation, and that several of them, if not all, contain a characteristic proportion of cells that leave the proliferative pool permanently, moving along the pathways of differentiation to approach, but in general not to attain, the final adult state. This is what is meant by the phrase "partially blocked ontogeny". Our insight into the meaning of the findings in transplantable hepatomas and autochthonous hepatomas requires a closer look at the changing phenotypic expression seen in foetal and neonatal liver, in regenerating liver after partial hepatectomy and precancerous liver (Fig. 8) .
The working hypothesis for our studies on carcinogenesis and differentiation in rat liver is illustrated in Fig. 9 gested in Fig. 9 . Table I illustrates how the labels in Fig. at parenchymal liver 9 might be distributed according to the ng a pathway that age of the animal. The Table is simply by certain enzymes another description of the model, and the and that cell pro-exact numbers need to be revised as better ltiated (in terms of data become available. However, a begin-G1) at more than one ning can be made at this time using known ay. Two such points parameters. Tables I and II. Alpha-foetoprotein and albumin production One of the parameters that is important in testing the model illustrated by Fig. 9 and Table I is cai-foetoprotein. DeNechaud and Uriel (1 971) have determined the level of AFP in serum of rats from before birth until 36 days of age, and in serum from rats with livers undergoing compensatory hyperplasia after CC14 damage. Secretion of AFP declined from a maximum at birth to nearly zero on the 32nd day. During this time serum albumin increased reciprocally, and reached its maximum plateau between 20 and 32 days after birth. Similar findings were reported by Watabe et al. (1972) whose data are shown in Fig. 10 as reproduced by Hirai et al. (1973) . Studies by Sell et al. (1974) also demonstrate the rapid decrease in AFP production by the livers of newborn rats. All 3 groups place the decline to the adult level of less than 0.1 [kg/ml at around 28 to 36 days of age. Tsukada and Hirai (1975) have examined the production of albumin and AFP production during the cell cycle in 2 hepatoma clones in synchronous culture. Synthesis of both occurred in late G1 and early S, declined in late S to zero in G2, M1 and early G. Immunofluorescent staining, showed that only a few cells were stained and that AFP and albumin stains were in different cells (coloured slide, courtesy of Dr Y. Tsukada). I feel that the available data (Tsukada and Hirai, 1975; DeNechaud and Uriel, 1971; Watabe et al., 1972; Hirai et al., 1973; Sell et al., 1974) support the model described in Fig.  9 and Table I. Further support comes from studies on AFP production by regenerating liver as a function of the age of the rat at partial hepatectomy (DeNechaud and Uriel, 1971; Sell et al., 1974 older than 7 weeks". They further suggested that "The resurgence of oxFP in hepatic injury of newborn rats and young rats is a consequence of the enhanced activity of some incompletely differentiated cell clones." Sell et al. (1974) carried out partial hepatectomy instead of using CC14 and used male rats at the ages of 5 and 7 weeks and adult males at about 300 g body weight. The decrease in AFP production with age was striking, and there was no significant production in the adults. They commented that "It is possible that a 'special' liver cell produces oaFP such as a transitory post-mitotic cell" and ". most hepatic parenchymal cells, particularly of the foetal rat, have the capacity to synthesize nlFP" (italics added). Again the data support the model of 2 classes of proliferating parenchymal cells. Blocks in the process of differentiation could explain the fact that some hepatomas secrete large amounts of AFP while others secrete essentially inone and all values between 04I jg/ml and 10,000 are represented (Sell and Morris, 1974) . I suggest that the AFP-secretory hepatomas are proliferating largely at the EH stage, with certain other hepatomas partially blocked and moving into the H and AH classes to some extent, and still others blocked prior to the stage at which AFP is produced. This description seems to fit the data of Tsukada and Hirai (1975) who found phenotypic heterogeneity within the 2 hepatoma clones with cells that were negative (due to position in cell cycle) and cells that were positive for either AFP or albumin (due, in my opinion, to their position in the partially blocked programme of parenchymalcell ontogeny).
Still another line of evidence suggesting de-repression and reversal from GoH to GoEH (Fig. 9) by carcinogens is based on AFP secretion by preneoplastic livers, which has been widely observed prior to appearance of actual nodules (Kroes et al., 1975) . Few studies have been carried out on AFP production by hepatomas or preneoplastic liver as a function of age atfirst exposure to carcinogen but a relevant study was carried out by Kroes et al. (1975) who found that "Rats started on aflatoxin B1 when 6 weeks old had more mixed liver tumours with neoplastic hepatocytes and bile ducts and higher AFP levels than did rats started at 26 weeks". Again the model (Fig. 9) appears to be supported.
Deoxycytidylic dearninase as a marker for the cycling early hepatocyte (EH)
Thymidine triphosphate is an essential building block for the synthesis of DNA, and it is of some interest that there are 3 alternative pathways leading to the formation of this compound. Number one is the well-known salvage or preformed pathway which begins with thymidine, the compound used in so many cell kinetic studies since Howard and Pelc (1953) . In competition with the salvage pathway are 2 de novo pathways, both of which involve reduction of ribotides to deoxyribotides. What is unexplained is that in one instance deoxyuridylic acid (dUMP) is formed directly (Pathway 2) while in the other case it is formed indirectly, that is, by the deamination of deoxycytidylic acid (dCMP) (Pathway 3). 
(CDP > (ICMP TdR What is proposed here is that the indirect Pathway 3 (Table II) is not essential for DNA synthesis in all proliferating liver cells and that dCMP deaminase is, in fact, a marker for an early stage of parenchymal liver-cell ontogeny, the cell cycle for the ER or Early Hepatocytes shown in Fig. 9 . It was shown by Pitot and Potter (1960) that normal adult and regenerating liver had very little activity compared with foetal liver (Table II) . Moreover, the Novikoff hepatoma had very high activity while the Dunning hepatoma had almost none. Preneoplastic liver also had elevated levels of dCMP deaminase (Pitot and Potter, 1960) at times that compare with times of elevated AFP (Kroes et al., 1975) .
As the methods for measuring activity became more sensitive, the enzyme became detectable in normal liver, and slight increases were found in regenerating liver and various hepatomas as shown by Maley and Maley (1960; 1961a, b) Sneider and Potter (1969) and Sneider et al. (1969) but the spread between high and low values remains.
The relative contribution of the 2 pathways (Nos. 2 and 3 in Table II) in regenerating liver cannot be judged by the presence of dCMP deaminase (Maley and Maley, 1960; 1961a, b; Sneider et al., 1969; Sneider and Potter, 1969 ) without a measure of the competing pathway. An entirely different inethod was used by Hecht and Potter (1956) who uised labelled orotic acid as a precursor, and measured ratios of labelled pyrimidine nucleotides in DNA. Further studies by Crone and Itzhaki (1965) supported our findings, and they concluded with us that the indirect pathway from dCMP to dUMP played a minor role in regenerating liver.
Thus, the small increase in dCMP deaminase in regenerating liver might be occurring in a population of early hepatocytes, as in Fig. 9 , and the variation between hepatomas might depend on whether the block in ontogeny occurred at the EH or the H level in Fig. 9 . Further studies on regenerating liver and preneoplastic liver at various ages with the aid of immunofluorescent techniques are needed to show whether dCMP deaminase in these tissues is restricted to a minority population of hepatocytes whose numbers decrease as the age of the rat increases, just as seems to be the case for AFP secretion (DeNechaud and Uriel, 1971; Sell et al., 1974) . -Early events in regenerating rat liver during transition from GoAII to GiH: the increase in amino-acid-transport activity. Data from Wondergem and Potter (to be published). Amino-acidtransport activity was studied by the preloading technique using (x-amino isobutyric acid (AIB). The "distribution ratio" is the tissue value divided by the blood value for each animal. Blood values were quite constant throughout.
Phenotypic diversity in the hormonal control of amino-acid transport Amino-acid-concentrating ability (i.e., active transport) can be conveniently studied with the aid of radioactive oaaminoisobutyric acid (AIB) because this compound is neither oxidized to CO2 nor incorporated into protein, and because it is actively transported. Since AIB is slowly excreted, it can be injected into the animal 24 h prior to killing and the steady-stateequilibrium values between tissue and blood can be determined under a variety of conditions. It appears that the aminoacid transport of the early hepatocyte (EH in Fig. 9 Fig. 9 .
Amino-acid transport in regenerating liver
After numerous experiments on regenerating and neonatal liver and on various hepatomas, we recently returned to the regenerating liver system in order to study the earliest events during the transition from GoAH to GoH to G1H (Fig.  9) . AIB was injected 24 h earlier and the distribution ratio was determined at various times up to 24 h after the surgery (Wondergem and Potter, to be published). Fig. 11 shows that after a short lag there was a marked increase in the AIB concentration in the livers by 3 h and that elevated levels were maintained for the entire subsequent period studied. Not shown is the fact that parallel increases were observed in the activity of ornithine decarboxylase, and from the literature similar early increases in prostaglandin (blocked by indomethacin) (McManus and Braceland, 1976) and serum glucagon (Leffert et al., 1976) were seen. These data suggest a possible connection between amino-acid transport and proliferation of liver cells, and suggest that regenerating liver may be responsive to glucagon. In the context of Fig. 9 and Table I (Pariza et al., 1976) . In cells pretreated with dexamethasone a marked increase in AIB transport was produced by glucagon ( Fig. 12 ) with a short lag quite similar to that observed in vivo (Fig. 11 ). Glucagon, with or without dexamethasone, produced a striking increase in the concentration of cyclic AMP within a few minutes (Fig. 12) . Although the adult-liver cells in cultured monolayers responded to glucagon with increased AIB transport in a manner comparable to that observed in regenerating liver in vivo, they did not proceed to the S phase (DNA synthesis) and did not proliferate. They appear to have remained at the (oAH stage shown in Fig. 9 . However, Leffert et al. (1976) have treated primary liver monolayers in their standard system, and demonstrated striking increases in thymidine incorporation into DNA by the addition of prostaglandin E. Thus, the data from experiments in vitro appear to be approaching the in vivo data. Again, as before, the questions of the relative contributions and relative initial concentrations of GoEH, GoH and GOAH cells remain unanswered, and the systematic study of cells from different ages of rats, with quantitation based on the identification of individual cells, remains for the future. However, helpful clues come from studies on neonatal rats and on transplantable Morris hepatomas.
Amino-acid transport in neonatal liver
Soon after the preloading technique for studying AIB was developed, we undertook studies on rats up to about 20 days of age. It was shown that AIB and cyclic AMP responses to glucagon were measurable at 0 to 2 days but that marked increases in response occurred between 2 and 10-20 days (Reynolds et al., 1971; . The data are compatible with the model presented in Fig. 9 and Table I tyrosine aminotransferase (Fig. 13) . Below an AIB distribution ratio of 5 at time zero in untreated animals, all hepatomas responded to injected glucagon with an increase in cyclic AMP that was in some cases equal to or greater than that of normal adult liver, and the resting values were similar to that for resting adult liver. These hepatomas thus approach the concept of minimal deviation with respect to adult liver. However, many hepatoma lines had initially elevated AIB ratios (10 to 30 compared to adult liver at about 3) and none of these hepatomas responded to glucagon with an increase in cAMP (Fig.  13) . Unexplained is their response with tyrosine aminotransferase, which was striking in some cases (Fig. 13) (Kelly and Potter, 1977 (Fig. 13) (Pierce et al., 1974) and to begin to label them for what they are, namely, "organism-serving molecules". In contrast to the balance between production of "self-serving" and "organism-serving" molecules in normal tissues, it is now clear that although many neoplasms have differentiated to the point that they are capable of producing one or several organism-serving molecules, they have in common the inability to carry on this activity in the orchestrated adaptive way that characterizes normal tissue in normal steady-state or adaptive conditions.
In the present discussion I have chosen to enlarge the Howard and Pelc (1953) concept of the cell cycle (with the Go adjunct proposed by Lajtha, 1963) (1973) and by Steel et al. (1966) .
The concept of "partially blocked ontogeny" seen in these terms is a further development of the "blocked ontogeny" hypothesis. It is not required that all the descendants of a neoplastic cell must reside at some point in the proliferative cycle. Indeed, even the most bizarre aneuploid neoplasms may produce one or several kinds of molecule in what has been called up to now the luxury-molecule category and that I now insist is the organismserving category. On this basis I now propose the dictum that any neoplasm that produces an organism-serving molecule is an example of "partially blocked ontogeny".
Most interesting from the standpoint of understanding the relation between carcinogenesis and differentiation are the minimally deviated neoplasms in which the line between the normal and the neoplastic is less and less obvious. In these cases the tumour is not fully autonomous, but merely "autonomous enough" under the given conditions, and as mentioned by Osgood (1957 Osgood ( , 1959 , by Pierce et al. (1974) and by Fibach et al. (1973) , it might be possible to tip further the balance from proliferation to differentiation so as to achieve therapeutic control.
In this lecture I have suggested that those of us not familiar with the studies on haemopoiesis have much to learn from current progress in that field, which seems to epitomize the feedback relations between differentiation, proliferation and neoplasia. At the same time I have emphasized that research on chemical carcinogenesis in liver is now ready with a variety of experimental approaches to study highly differentiated hepatomas, preneoplastic foci, and cell cultures that can further elucidate the relationship between differentiation, proliferation and neoplasia.
In a larger sense, I have endeavoured to justify my Tokyo statement that by 1978 "a comprehensive and penetrating understanding of the molecular and biological nature of cancer" would be near at hand. Some of the uncertainties in differentiation have been mentioned by Coleman (1976) in reviewing Cell Cycle and Cell .Differentiation by Reinert and Holtzer as follows: "It is once again apparent from this volume that cell differentiation and the cell cycle are intriguingly coupled, but experimental evidence so far provides no mechanistic basis for choosing between the relatively cataclysmic model of quantal mitosis and a model of more gradual reprogramming accompanying cyclic changes in the state of the genetic material."
On the positive side, we have the proposals by Holliday and Pugh (1975) who developed a model of development based on "a continual interaction between cytoplasmic enzymes and DNA sequences ... these cytoplasmic components are, of course, usually derived from the activity of genes at some earlier stage in development... The use ofdevelopmental mutants is probably essential, since by comparison with wild-type organisms it may be possible to identify the nature of their biochemical defects [compare with Lotem and Sachs (1974) above]. ... We proposed that the same ordered control of the transcription of genes could be achieved by the methylation of bases, without changes in sequence." They concluded with the idea of "repeated sequences of controlling DNA, which could dissociate from and reassociate with several chromosomal sites by means ofgenetic recombination. What may now be needed is an examination of these genetic elements in a higher organism in which both biochemical and genetic studies can be undertaken."
At this point I must conclude my lecture as in a novel in serial form: "to be continued". However, I must say that the need for synthesis, for the conversion of knowledge to wisdom, has never been greater, owing to the volume of data, and I must re-emphasize the fact that neither I nor anyone else is capable of achieving the needed synthesis alone and unaided (Potter 1956 ). The present effort accordingly invites needed discussion.
